Veracyte, Inc. (VCYT)
42.44
-0.33
(-0.77%)
USD |
NASDAQ |
Dec 26, 10:51
Veracyte Shareholders Equity (Quarterly): 1.258B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 51.02B |
| FONAR Corp. | 174.87M |
| XWELL, Inc. | -6.333M |
| ProPhase Labs, Inc. | 6.861M |
| Insight Molecular Diagnostics, Inc. | -9.196M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.368B |
| Total Liabilities (Quarterly) | 110.12M |
| Debt to Equity Ratio | 0.0322 |
| Current Ratio | 6.226 |
| Net Debt Paydown Yield | -0.15% |